Comparative efficacy of fluconazole and amphotericin B in the parenteral treatment of experimental paracoccidioidomycosis in the rat

Mycopathologia

Volumn 146, Issue 3, 1999, Pages 131-134

  Martinez, Roberto ^a   Malta, Maria Helena Borges ^a   Verceze, Adalberto Valadas ^a   Arantes, Mauricio Rodrigues ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amphotericin B; Fluconazole; Paracoccidioidomycosis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ANIMAL; ARTICLE; BACTERIAL COUNT; COMPARATIVE STUDY; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PARACOCCIDIOIDES; RAT; SOUTH AMERICAN BLASTOMYCOSIS; WISTAR RAT;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; COLONY COUNT, MICROBIAL; FEMALE; FLUCONAZOLE; HUMANS; PARACOCCIDIOIDES; PARACOCCIDIOIDOMYCOSIS; RATS; RATS, WISTAR;

ANIMALIA; BACTERIA (MICROORGANISMS); FUNGI; PARACOCCIDIOIDES BRASILIENSIS; PARACOCCIDIOIDOMYCOSIS BRASILIENSIS;

EID: 0343237783     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007013808797     Document Type: Article

References (12)

1. Espinel-Ingroff A, Kerkering TM, Negroni R, Restrepo A. Susceptibilities of the yeast and mycelial phase of Paracoccidioides brasiliensis to five antifungal agents. Rev Argent Micol 1992; 15: 30 (Abstract).
2. Negroni R, Elias Costa MRI, Finquelievich JL, Iovannitti C, Agorio IL, Tiraboschi IN. Three triazoles in the treatment of experimental paracoccidioidomycosis. Rev Iberoamer Micol 1991; 8: 8-12.
3. Brummer E, Castaneda E, Restrepo A. Paracoccidioidomycosis: an update. Clin Microbiol Rev 1993; 6: 89-117.
4. Mendes RP, Negroni R, Arechavala A. Treatment and control of cure. In: Franco M, Lacaz CS, Restrepo-Moreno A, Del Negro G, eds. Paracoccidioidomycosis. Boca Raton: CRC Press, 1994: 373-392.
5. Negroni R, Robles AM, Arechavala A, Taborda A. Experiencia terapeutica con el fluconazol en las micosis profundas. Rev Argent Micol 1990; 13: 26-32.
6. Diaz M, Negroni R, Montero-Gei F, Castro LMG, Sampaio SAP, Borelli D, Restrepo A, Franco L, Bran JL, Arathoon EG, Stevens DA, and other investigators of the Fluconazole Pan-American Study Group. A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Clin Infect Dis 1992; 14: S68-S76.
7. Singer-Vermes LM, Ciavaglia MC, Kashino SS, Burger E, Calich VLG. The source of the growth-promoting factor(s) affects the plating efficiency of Paracoccidioides brasiliensis. J Med Vet Mycol 1992; 30: 261-264.
8. Stevens DA, Brummer E, McEwen JG, Perlman A. Efficacy of fluconazole, a new oral triazole, in blastomycosis and paracoccidioidomycosis and in comparison with ketoconazole. Rev Iber Micol 1988; 5 (suppl 1): 26 (Abstract).
9. Louie A, Drusano GL, Banerjee P, Liu Q-F, Kaw P, Shayegani M, Taber H, Miller MH. Pharmacodynamics of fluconazole in a murine model of systemic candidiasis. Antimicrob Agents Chemother 1998; 42: 1105-1109.
10. Sanati H, Ramos CF, Bayer AS, Ghannoum MA. Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models. Antimicrob Agents Chemother 1997; 41: 1345-1348.
11. Kobayashi GS, Travis SJ, Medoff G. Comparison of fluconazole with amphotericin B in treatment of histoplasmosis in normal and immunosuppressed mice. Rev Infect Dis 1990; 12: S291-S293.
12. Patterson TF, Miniter P, Andriole VT. Efficacy of fluconazole in experimental invasive aspergillosis. Rev Infect Dis 1990; S281-S285.